Lenox Wealth Advisors’s CONMED CNMD Stock Holding History

Lenox Wealth Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-14	Closed	-$1K	–	440
2019 Q1	$1K	Buy	+14	New	+$1.02K	﹤0.01%	577

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Lenox Wealth Advisors's CNMD Position: Q2 2019 in Review

Lenox Wealth Advisors sold out of CONMED (CNMD) in Q2 2019, closing a stake of 14 shares — an estimated $1K sold.

Lenox Wealth Advisors first reported a position in CNMD in Q1 2019 and held it in 1 quarter. The position peaked at $1K in Q1 2019. 230 funds tracked by Wall St. Rank hold CNMD as of Q2 2019.

Lenox Wealth Advisors reported no remaining CONMED position as of Q2 2019 after selling out during the quarter.
Lenox Wealth Advisors sold 14 CONMED shares in Q2 2019, an estimated $1K.
Lenox Wealth Advisors first reported a position in CONMED in Q1 2019 and held it in 1 quarter.
Lenox Wealth Advisors's CONMED position peaked at $1K in Q1 2019.
230 funds tracked by Wall St. Rank held CONMED as of Q2 2019.

Based on Lenox Wealth Advisors's 13F filing for Q2 2019, filed 12 Jul 2019.